Topic Code HORIZON-HLTH-2026-01-CARE-01 F&T Portal
Call Identifier HORIZON-HLTH-2026-01 Call 01 — single stage (2026)
Instrument HORIZON-PPI Public Procurement of Innovative Solutions
Budget Model Actual Costs PPI procurement costs
Funding Rate 100% PPI — 100% procurement costs
Page Limit (Part B) 40 pages PPI + actual costs (General Annex H)
Evaluation Thresholds 3 / 3 / 3 · cum. 10 Standard — no override
Expected Projects 4 €3–8M per project (WP stated)
Destination Ensuring equal access to innovative, sustainable, and high-quality healthcare WP Part 4
Cluster / Pillar Cluster 1 / Pillar II Health
China Eligibility Eligible ✓ PPI not restricted (RIA/IA only)
Special Conditions PPI action ⚠ Section H conditions apply
Verify: Open this topic on the F&T Portal →  ·  Sources: General Annexes 2026-2027, WP Part 4
See what a full Decision Brief looks like →
Compliance traps · Scoring playbook · Consortium blueprint · 2 free examples available
This is a PPI (Public Procurement of Innovative Solutions) action. Different rules apply compared to standard RIA/IA/CSA. The specific conditions in Section H of the General Annexes apply. Financial support to third parties is allowed (max €60,000 per party).
Communication networks restriction: Entities assessed as high-risk suppliers of mobile network communication equipment (and entities they own or control) are not eligible to participate in this topic.
US entities eligible: In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, legal entities established in the United States of America are eligible to receive Union funding under this topic.
Copernicus/Galileo: If the project uses satellite-based earth observation, positioning, navigation and/or related timing data, beneficiaries must make use of Copernicus and/or Galileo/EGNOS.

Expected Outcomes

  1. Patients and their carers, health authorities and health professionals will benefit from the deployment of innovative solutions, designed around actual clinical needs, that facilitate identification, integration or coordination of care, allowing for personalised, more accessible, inclusive and higher quality of health and care.
  2. Patients will benefit from personalised approaches, improved care experiences and health outcomes or are more engaged in their care and better equipped to make informed decisions on their health, in collaboration with health professionals.
  3. Health professionals will be better equipped with, and thus benefit from, improved means for diagnosis, care delivery and/or coordination, with multi-disciplinary approaches and closer patient engagement, thanks to new technologies.
  4. Health systems will improve their accessibility, coordination mechanisms, effectiveness, inclusivity and resilience, thanks to innovative solutions, with a better use of resources, thus stimulating organisational innovation, cultural transformation within hospitals, and European-level collaboration.

Want the full analysis?

The key facts above tell you WHAT. The full Decision Brief tells you HOW to win.

Compliance traps Scoring playbook Consortium blueprint Positioning guide Red flags Quick-start checklist
Order Full Brief — €79
Delivered within 1 working day
Disclaimer: This page is produced using advanced AI analysis and reviewed by an experienced EU grant engineer. While we take care to ensure accuracy, the information may contain errors or become outdated. It is the applicant’s sole responsibility to verify all facts against the official EU Funding & Tenders Portal before making any decisions. Global Disruption accepts no liability for errors, omissions, or decisions made based on this content. No refunds are offered for Key Facts pages or Decision Briefs.